Answer
It is a targeted monoclonal antibody rather than conventional cytotoxic chemotherapy, although it is often combined with chemotherapy or other anti-myeloma treatments.
Sources for this answer
- DARZALEX 1,800 mg solution for injection — Current selected SmPCemc · Summary of Product Characteristics
- DARZALEX 20 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.